Greg Slabodkin - Profile and Journalist Details

Find journalists that align with your industry, location and vision. Unlock Greg Slabodkin's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.

Get connected with journalists today
Greg Slabodkin

Greg Slabodkin

Verified

Editor-in-Chief, Pharma Manufacturing

Buffalo

Final Covers

Business Climate ChangeEnvironment

Doesn’t Cover

Business, medical

Journalist Type

-

Seniority Positions

Industries

Medium Formats

-

Content

Total articles 4145

  • Sartorius sees net profit jump 21.4% in Q1, expects biologics demand to continue to rise

    By Greg Slabodkin Verified| Pharma Manufacturing Verified German pharma and lab equipment company Sartorius announced that it achieved significant profitable growth in the first quarter of 2025, with net profit jumping 21.4% and sales revenue increasing 7.7% in Q1 on a reported basis. Sartorius credited the “strong start to the year” to a nearly 10% revenue increase in the quarter for its Bioprocess Solutions division, which supports the manufacture of biopharmaceuticals.

    By Greg Slabodkin Verified · Pharma Manufacturing

    Apr. 15, 2025

  • J&J CEO says tax policy, not tariffs, needed to incentivize US pharma manufacturing

    By Greg Slabodkin Verified| Pharma Manufacturing Verified Tax policy, not tariffs, are the most effective way for President Donald Trump to bring pharmaceutical manufacturing back to the United States, according to Johnson & Johnson CEO Joaquin Duato. “If what you want is to build manufacturing capacity in the U.S., both in medtech and in pharmaceuticals, the most effective answer is not tariffs but tax policy,” Duato told investors on J&J’s earnings call Tuesday morning.

    By Greg Slabodkin Verified · Pharma Manufacturing

    Apr. 14, 2025

  • Sartorius sees net profit jump 21.4% in Q1, expects biologics demand to continue to rise

    By Greg Slabodkin Verified| Pharma Manufacturing Verified German pharma and lab equipment company Sartorius announced that it achieved significant profitable growth in the first quarter of 2025, with net profit jumping 21.4% and sales revenue increasing 7.7% in Q1 on a reported basis. Sartorius credited the “strong start to the year” to a nearly 10% revenue increase in the quarter for its Bioprocess Solutions division, which supports the manufacture of biopharmaceuticals.

    By Greg Slabodkin Verified · Pharma Manufacturing

    Apr. 15, 2025

As seen in

Company Info

Pharma Manufacturing

Chemical Processing provides news and analysis for the chemical industry, allowing U.S. chemical companies to remain efficient, safe, and economically competitive.

Washington, D.C., United States

+1 630-467-1300

Founded: 1938